Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:17:11 EST Wed 11 Feb 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:DTCFF - DEFENCE THERAPEUTICS INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DTCFF - Qnot subscribed0.4482-0.0118-2.62.3160.4405  0.4482  0.44051.1575  0.3446Feb 10Feb 1015 min RT 2¢

Recent Trades - All 6 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-10 03:16U:DTCFFNews ReleaseDefence Therapeutics Aligns Accum ADC Strategy Through Multidisciplinary Scientific Advisory Board
2026-02-04 03:16U:DTCFFNews ReleaseDefence Therapeutics to Present at the World ADC Europe 2026 Showcasing Accum Precision Intracellular Drug-Delivery Platform
2026-01-28 08:41U:DTCFFNews ReleaseDefence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline
2026-01-21 03:16U:DTCFFNews ReleaseDefence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics
2025-12-11 08:35U:DTCFFNews ReleaseDefence Therapeutics to Present at the Life Sciences Virtual Investor Forum December 11th
2025-12-10 16:31U:DTCFFNews ReleaseDefence Therapeutics Announces AGM Results and Provides Corporate Updates
2025-12-04 03:17U:DTCFFNews ReleaseDefence Therapeutics Announces Formation of Scientific Advisory Board to Guide Advancement of Accum-Enhanced Antibody Drug Conjugate Programs
2025-11-21 18:04U:DTCFFNews ReleaseDefence Therapeutics Announces Convertible Debenture Conversion
2025-11-19 03:16U:DTCFFNews ReleaseDefence Therapeutics to Build ADC Drug Delivery Powerhouse Using Its Proprietary Accum Technology
2025-11-06 03:17U:DTCFFNews ReleaseDefence Announces Successful Presentation at the World ADC Conference in San Diego and Plans to Expand Evaluation of Accum in Commercial and Pipeline ADCs
2025-11-04 03:16U:DTCFFNews ReleaseDefence Therapeutics Demonstrates Strong Preclinical in Vivo Efficacy Results Evaluating Accum-Kadcyla in Breast Cancer Models
2025-10-23 03:16U:DTCFFNews ReleaseDefence to Present New Scientific Data on Its ADC-Enhancing Accum Technology at the World ADC Conference in San Diego, USA, November 4-5, 2025
2025-10-06 03:16U:DTCFFNews ReleaseDefence Therapeutics to Attend CPHI Worldwide in Frankfurt, October 28-30, 2025
2025-10-02 03:16U:DTCFFNews ReleaseDefence Therapeutics Appoints Dr. Mark Lambermon as Head of Quality and Operations
2025-09-23 09:16U:DTCFFNews ReleaseDefence's Director, Strategy & Business Advisor Dr. Amie Phinney Discusses the Accum Platform on Money Talk Radio with Ellis Martin
2025-09-23 03:03U:DTCFFNews ReleaseEllis Martin Report: Dr. Amie Phinney of Defence Therapeutics Inc. (DTCFF) on the Accum(TM) Platform
2025-09-16 03:16U:DTCFFNews ReleaseDefence Therapeutics Appoints Dr. Amie Phinney as Director
2025-09-15 16:31U:DTCFFNews ReleaseDefence Therapeutics Completes Fully Subscribed Debenture Units Financing of $2,000,000
2025-09-02 03:16U:DTCFFNews ReleaseDefence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth
2025-08-22 20:31U:DTCFFNews ReleaseDefence Therapeutics Announces Debenture Units Financing